TW200813070A - Antiviral agents - Google Patents

Antiviral agents Download PDF

Info

Publication number
TW200813070A
TW200813070A TW096125693A TW96125693A TW200813070A TW 200813070 A TW200813070 A TW 200813070A TW 096125693 A TW096125693 A TW 096125693A TW 96125693 A TW96125693 A TW 96125693A TW 200813070 A TW200813070 A TW 200813070A
Authority
TW
Taiwan
Prior art keywords
substituted
group
methyl
compound
amino
Prior art date
Application number
TW096125693A
Other languages
English (en)
Chinese (zh)
Inventor
Franz Ulrich Schmitz
Christopher Don Roberts
Ronald Conrad Griffith
Janos Botyanszki
Son Minh Pham
Original Assignee
Genelabs Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc filed Critical Genelabs Tech Inc
Publication of TW200813070A publication Critical patent/TW200813070A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW096125693A 2006-07-14 2007-07-13 Antiviral agents TW200813070A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83104006P 2006-07-14 2006-07-14

Publications (1)

Publication Number Publication Date
TW200813070A true TW200813070A (en) 2008-03-16

Family

ID=38742551

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096125693A TW200813070A (en) 2006-07-14 2007-07-13 Antiviral agents

Country Status (13)

Country Link
EP (1) EP2044083A1 (ja)
JP (1) JP2009543807A (ja)
KR (1) KR20090033881A (ja)
CN (1) CN101490058A (ja)
AR (1) AR062258A1 (ja)
AU (1) AU2007272441A1 (ja)
BR (1) BRPI0714346A2 (ja)
CA (1) CA2657651A1 (ja)
MX (1) MX2009000513A (ja)
PE (1) PE20080427A1 (ja)
RU (1) RU2009105196A (ja)
TW (1) TW200813070A (ja)
WO (2) WO2008008912A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
ATE548044T1 (de) 2007-05-04 2012-03-15 Vertex Pharma Kombinationstherapie zur behandlung von hiv- infektionen
CN102822175A (zh) 2009-12-18 2012-12-12 埃迪尼克斯医药公司 5,5-稠合的亚芳基或亚杂芳基丙型肝炎病毒抑制剂
CA2822357A1 (en) * 2010-12-22 2012-06-28 Abbvie Inc. Hepatitis c inhibitors and uses thereof
US20120252721A1 (en) * 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
FR3008975A1 (fr) 2013-07-23 2015-01-30 Servier Lab Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
US10080728B2 (en) 2015-01-20 2018-09-25 Viktor Veniaminovich Tets Hemostatic agent
US10167293B2 (en) * 2016-05-26 2019-01-01 Bayer Pharma Aktiengesellschaft [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
JP7475144B2 (ja) 2017-05-24 2024-04-26 ヴェニアミノヴィッチ テッツ ヴィクトル 分画抗菌組成物およびその使用
IL307203A (en) * 2021-04-16 2023-11-01 Gilead Sciences Inc THIENOPYRROLE COMPOUNDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1753A (en) * 2001-06-11 2007-07-18 Shire Biochem Inc Thiophene derivatives as antiviral agents for flavvivirus infection
TW200504028A (en) * 2003-06-04 2005-02-01 Genelabs Tech Inc Nitrogen-containing heteroaryl derivatives

Also Published As

Publication number Publication date
PE20080427A1 (es) 2008-06-11
WO2008008907A3 (en) 2008-03-20
WO2008008912A1 (en) 2008-01-17
BRPI0714346A2 (pt) 2013-03-19
CA2657651A1 (en) 2008-01-17
CN101490058A (zh) 2009-07-22
AR062258A1 (es) 2008-10-29
WO2008008907A2 (en) 2008-01-17
MX2009000513A (es) 2009-03-09
AU2007272441A2 (en) 2009-03-19
EP2044083A1 (en) 2009-04-08
JP2009543807A (ja) 2009-12-10
RU2009105196A (ru) 2010-08-27
AU2007272441A1 (en) 2008-01-17
KR20090033881A (ko) 2009-04-06

Similar Documents

Publication Publication Date Title
TW200813070A (en) Antiviral agents
KR101653548B1 (ko) 2-｛4-［（3ｓ）-피페리딘-3-일］페닐｝-2ｈ-인다졸-7-카복스아미드의 약제학적으로 허용되는 염
ES2524787T3 (es) Derivados de piridazinona como inhibidores de PARP
JP4616831B2 (ja) Ａｋｔ活性の阻害剤
US20060211698A1 (en) Bicyclic heteroaryl derivatives for treating viruses
TW591022B (en) Tetrahydropyridino or piperidino heterocyclic derivatives
US20060264430A1 (en) Pyrazole derivative
CA2613261A1 (en) Heteroaryl derivatives for treating viruses
KR20070096038A (ko) Ｍｇｌｕｒ５ 길항제로서 사용하기 위한 피롤리딘 및피페리딘 아세틸렌 유도체
JP2009544622A (ja) 多環式ウイルス阻害剤
US20190263828A1 (en) Heteroaromatic compounds as vanin inhibitors
WO2005049622A1 (ja) ５－５員縮合複素環化合物及びそのｈｃｖポリメラーゼ阻害剤としての用途
TW200526606A (en) Substituted triazole derivatives as oxytocin antagonists
US9533999B2 (en) Fused thiazin-3-ones as KCA3.1 inhibitors
US20080051384A1 (en) Antiviral agents
AU2016341259A1 (en) Pyridone derivatives and their use as kinase inhibitors